Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.

You may be eligible if

• Patients eligible to be prescribed fluticasone/formoterol fixed dose combination as follows:
• Patients not adequately controlled in inhaled corticosteriods and "as required" inhaled short acting beta 2 agonist or patients already adequately controlled on both an inhaled corticosteriod and a long-acting beta 2 agonist.
• The decision to prescribe fluticasone/formoterol fixed dose combination will precede and be independent of the decision to enroll the patient into the study